Skip to main content

Table 3 Clinical characteristics of patients who received CIT for ≥ 3 courses or < 3 courses

From: Cellular immunotherapy as maintenance therapy prolongs the survival of the patients with small cell lung cancer

Clinical features CIT ≥ 3 courses CIT < 3 courses P-value
Sex
Male 11 11 0.187
Female 6 1
Age, years
Median (range) 61 (41–79) 64 (54–78) 0.107
Smoking index
Median (range) 400 (0–1000) 350 (0–2000) 0.751
ECOG
≤1 16 9 0.279
2 1 3
Chemotherapy courses    
Median 6 6 0.713
Range 4–6 4–6
Radiotherapy    
Yes 16 9 0.279
No 1 3  
Surgery
Yes 3 1 0.622
No 14 11
Chemotherapy responses *
CR 5 2 0.707
PR 7 7
SD 5 3
Stage
Limited 10 7 1.000
Extensive 7 5
  1. Abbreviations: CIT, cellular immunotherapy; ECOG, Eastern Cooperative Oncology Group; CR, complete remission; PR, partial remission; SD, stable disease
  2. Note: *The responses for the first-line therapy